HHealthcare Read More Another alliance of health care and AI signals why pharma stocks could be backJanuary 21, 2026 Bristol Myers Squibb and Microsoft ‘s new partnership aimed at accelerating early detection of lung cancer marks the…
HHealthcare Read More Novo Nordisk shares rise after Wegovy obesity pill launchJanuary 16, 2026 A pharmacist displays a box of Wegovy pills at a pharmacy in Provo, Utah, US, on Thursday, Jan.…
HHealthcare Read More Secretive Project Prometheus takes VC Bob Nelsen beyond just health careJanuary 15, 2026 Allison DeAngelis is the East Coast biotech and venture capital reporter at STAT, reporting where scientific ideas and…
SScience Read More Bacillus velezensis mitigates deoxynivalenol-induced intestinal inflammation and liver injury via modulating the gut microbiotaJanuary 14, 2026 Pestka, J. Toxicological mechanisms and potential health effects of deoxynivalenol and nivalenol. World Mycotoxin J. 3, 323–347 (2010).…
BBusiness Read More Investor Noubar Afeyan warns against a backlash to science in the U.S.January 13, 2026 SAN FRANCISCO — Noubar Afeyan, one of biotech’s top investors, warned in an annual letter that a backlash…
TTechnology Read More Whole-genome sequencing improves PARP inhibitor treatment predictionJanuary 12, 2026 A whole-genome sequencing approach shows early promise over current commercial methods for identifying more patients likely to benefit…
HHealthcare Read More First GLP-1 pill for obesity from Novo Nordisk launches in the U.S.January 5, 2026 The logo of pharmaceutical company Novo Nordisk is displayed in front of its offices in Bagsvaerd, on the…
SScience Read More Endonuclease V activated Pyrococcus furiosus Argonaute for the detection of food contaminated bacteriaDecember 31, 2025 Banada, P. P. et al. Label-free detection of multiple bacterial pathogens using light-scattering sensor. Biosens. Bioelectron. 24, 1685–1692…
HHeadlines Read More Pill version of Novo Nordisk’s Wegovy approved, possibly widening accessDecember 23, 2025 The Food and Drug Administration on Monday approved the oral version of Novo Nordisk’s injectable weight loss drug…
HHealth Read More Blocking platelet-activating factor reduces liver damage in cirrhosisDecember 20, 2025 Researchers from Miguel Hernández University of Elche (UMH) in Spain have identified an effective strategy to reduce structural…
HHealthcare Read More Pharma’s ‘Dr. Optimistic’ is worried about the industry’s futureDecember 20, 2025 In July 2006, The New York Times sent young reporter Alex Berenson to Pfizer to interview me about…
HHealthcare Read More UnitedHealth Group releases results of independent auditDecember 19, 2025 UnitedHealthcare sign is displayed at its office building in Minnetonka, Minnesota, U.S., Dec. 11, 2025. Tim Evans |…